A critical evaluation of drug delivery from ligand modified nanoparticles: Confounding small molecule distribution and efficacy in the central nervous system

scientific article

A critical evaluation of drug delivery from ligand modified nanoparticles: Confounding small molecule distribution and efficacy in the central nervous system is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.JCONREL.2015.10.013
P932PMC publication ID4688251
P698PubMed publication ID26471392
P5875ResearchGate publication ID282912120

P50authorRebecca L. McCallQ41781274
Rachael W SirianniQ41781277
Kyle T HouseholderQ56994044
P2093author name stringAlesia V Prakapenka
Danielle M DiPerna
Eugene P Chung
P2860cites workSqualenoyl adenosine nanoparticles provide neuroprotection after stroke and spinal cord injury.Q27311418
Camptothecins: a review of their chemotherapeutic potentialQ28203339
The blood-spinal cord barrier: morphology and clinical implicationsQ28240807
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomesQ29617554
Current review of in vivo GBM rodent models: emphasis on the CNS-1 tumour modelQ34198939
Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncologyQ34328650
Drug delivery to the central nervous system by polymeric nanoparticles: what do we know?Q34367038
Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology.Q34447986
Adsorption of plasma proteins on uncoated PLGA nanoparticles.Q34581713
Transvascular delivery of small interfering RNA to the central nervous system.Q34638044
Targeting caspase-3 as dual therapeutic benefits by RNAi facilitating brain-targeted nanoparticles in a rat model of Parkinson's diseaseQ34722724
Radiolabeling of poly(lactic-co-glycolic acid) (PLGA) nanoparticles with biotinylated F-18 prosthetic groups and imaging of their delivery to the brain with positron emission tomographyQ34764435
Highly penetrative, drug-loaded nanocarriers improve treatment of glioblastomaQ34789136
Pathogen-inspired drug delivery to the central nervous systemQ34929922
Intracranial implantation with subsequent 3D in vivo bioluminescent imaging of murine gliomasQ35841577
Rabies virus receptorsQ36086325
Beyond the imaging: limitations of cellular uptake study in the evaluation of nanoparticlesQ36247616
Spatial distribution and acute anti-inflammatory effects of Methylprednisolone after sustained local delivery to the contused spinal cordQ36633104
Release of hydrophobic molecules from polymer micelles into cell membranes revealed by Forster resonance energy transfer imagingQ36638691
Strategy for effective brain drug delivery.Q37760347
Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current statusQ38135674
The significance of transferrin receptors in oncology: the development of functional nano-based drug delivery systemsQ38175442
Functional nanoparticles in targeting glioma diagnosis and therapiesQ38204417
Nanocarrier-based therapies for CNS tumorsQ38233169
A new tool to ensure the fluorescent dye labeling stability of nanocarriers: a real challenge for fluorescence imagingQ39136552
Targeted imaging of activated caspase-3 in the central nervous system by a dual functional nano-deviceQ39278038
A brain-targeted rabies virus glycoprotein-disulfide linked PEI nanocarrier for delivery of neurogenic microRNA.Q39559308
RVG-mediated calpain2 gene silencing in the brain impairs learning and memoryQ39567298
RVG peptide tethered bioreducible polyethylenimine for gene delivery to brainQ39662401
Intracellular drug delivery by poly(lactic-co-glycolic acid) nanoparticles, revisitedQ39911958
Sustained intraspinal delivery of neurotrophic factor encapsulated in biodegradable nanoparticles following contusive spinal cord injuryQ39942829
Antibody targeting of camptothecin-loaded PLGA nanoparticles to tumor cells.Q39961374
Intravenous delivery of camptothecin-loaded PLGA nanoparticles for the treatment of intracranial glioma.Q41619756
PLGA nanoparticles formed by single- or double-emulsion with vitamin E-TPGS.Q41781215
Rabies virus glycoprotein (RVG) is a trimeric ligand for the N-terminal cysteine-rich domain of the mammalian p75 neurotrophin receptorQ44090700
Targeted delivery of proteins into the central nervous system mediated by rabies virus glycoprotein-derived peptideQ45360534
Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticlesQ45384244
Targeted brain delivery of itraconazole via RVG29 anchored nanoparticlesQ48169419
Brain-targeted delivery of protein using chitosan- and RVG peptide-conjugated, pluronic-based nano-carrierQ48310007
Quantification and localization of PEGylated polycyanoacrylate nanoparticles in brain and spinal cord during experimental allergic encephalomyelitis in the rat.Q48614110
Measurement of cerebral blood volume in mouse brain regions using micro-computed tomographyQ48663323
Nanocarrier-mediated inhibition of macrophage migration inhibitory factor attenuates secondary injury after spinal cord injuryQ50218527
Evaluation of antimetastatic activity and systemic toxicity of camptothecin-loaded microspheres in mice injected with B16-F10 melanoma cells.Q51161893
Surface modification of biodegradable polyesters with fatty acid conjugates for improved drug targeting.Q51475399
GABAA and GABAB receptor site distribution in the rat central nervous systemQ70180394
A rapid method for removal of the spinal cordQ70193245
Targeted delivery of large fusion protein into hippocampal neurons by systemic administrationQ85173790
P4510describes a project that usesImageJQ1659584
P433issuePt A
P407language of work or nameEnglishQ1860
P921main subjectnanoparticleQ61231
drug deliveryQ1392806
P304page(s)89-97
P577publication date2015-10-12
P1433published inJournal of Controlled ReleaseQ6295046
P1476titleA critical evaluation of drug delivery from ligand modified nanoparticles: Confounding small molecule distribution and efficacy in the central nervous system
P478volume220